Professor | Anyu Bao | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Anyu Bao

Contact Information

bay@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1999-2004: Bachelor in Clinical Medicine from Wuhan University 2004-2006: Master in Pathogen Biology from Wuhan University 2010-2014: PhD in Clinical Laboratory Diagnostics from Wuhan University Lead on 1 National Natural Science Foundation project, involved in 2 National Key R&D Plan projects
Work Experience	2006-2015: Attending Physician, Clinical Laboratory, Renmin Hospital, Wuhan University 2015-2022: Deputy Chief Physician, Clinical Laboratory, Renmin Hospital, Wuhan University 2022-Present: Chief Physician, Associate Professor, Clinical Laboratory, Renmin Hospital, Wuhan University

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1999-2004: Bachelor in Clinical Medicine from Wuhan University
2004-2006: Master in Pathogen Biology from Wuhan University
2010-2014: PhD in Clinical Laboratory Diagnostics from Wuhan University
Lead on 1 National Natural Science Foundation project, involved in 2 National Key R&D Plan projects

Work Experience

2006-2015: Attending Physician, Clinical Laboratory, Renmin Hospital, Wuhan University
2015-2022: Deputy Chief Physician, Clinical Laboratory, Renmin Hospital, Wuhan University
2022-Present: Chief Physician, Associate Professor, Clinical Laboratory, Renmin Hospital, Wuhan University

Areas of Focus	Tumor liquid biopsy and personalized therapy Molecular mechanism of the genesis and development of neurodegenerative diseases
Publications	5’/3’ imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer, Tong Yongqing, Zhao Zhijun, Liu Bei, Bao AY, Zheng Hongyun, Gu Jian, McGrath Mary, Xia Ying, Tan Bihua, Song Chunhua, Li Yan, 2018 N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity, Zhou L, Guo T, Meng L, Zhang X, Tian Y, Dai L, Niu X, Li Y, Liu C, Chen G, Liu C, Ke W, Zhang Z, Bao A, Zhang Z, 2023 A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques, Zitao Wang, Anyu Bao, Shiyi Liu, Fangfang Dai, Yiping Gong, Yanxiang Cheng, 2022 Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway, Yang D, Wang Y, Zheng Y, Dai F, Liu S, Yuan M, Deng Z, Bao A, Cheng Y, 2021 Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer, Wu Q, Zheng H, Gu J, Cheng Y, Qiao B, Wang J, Xiong L, Sun S, Wu Z, Bao A, Tong Y, 2021 DNA Methylation and Recurrent Pregnancy Loss: A Mysterious Compass?, Zhou Q, Xiong Y, Qu B, Bao A, Zhang Y, 2021

Areas of Focus

Tumor liquid biopsy and personalized therapy
Molecular mechanism of the genesis and development of neurodegenerative diseases

Publications

5’/3’ imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer, Tong Yongqing, Zhao Zhijun, Liu Bei, Bao AY, Zheng Hongyun, Gu Jian, McGrath Mary, Xia Ying, Tan Bihua, Song Chunhua, Li Yan, 2018
N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity, Zhou L, Guo T, Meng L, Zhang X, Tian Y, Dai L, Niu X, Li Y, Liu C, Chen G, Liu C, Ke W, Zhang Z, Bao A, Zhang Z, 2023
A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques, Zitao Wang, Anyu Bao, Shiyi Liu, Fangfang Dai, Yiping Gong, Yanxiang Cheng, 2022
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway, Yang D, Wang Y, Zheng Y, Dai F, Liu S, Yuan M, Deng Z, Bao A, Cheng Y, 2021
Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer, Wu Q, Zheng H, Gu J, Cheng Y, Qiao B, Wang J, Xiong L, Sun S, Wu Z, Bao A, Tong Y, 2021
DNA Methylation and Recurrent Pregnancy Loss: A Mysterious Compass?, Zhou Q, Xiong Y, Qu B, Bao A, Zhang Y, 2021

Biopsy Cancer Therapy Personalized Molecular Neurodegeneration Mechanism Development Disease Genetics

Jin-Xuan Hou - Wuhan University

Meiyan Liao - Wuhan University

Jingling Xue - Wuhan University

View All

Personal Information